CD8A and neoplasm: In addition, studies have demonstrated the modulating effects of mTORC1/2 on diverse human cells such as CD4, CD8, Treg, tumor-associated macrophages TAM, cancer-associated fibroblasts CAF, endothelial cells, and MDSCs (myeloid-derived suppressor cells) [10,11].